Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Dasabuvir Sodium on PharmaCompass.com

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9333204

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2035-01-02

Patent Use Code

U-1889

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8691938

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2032-04-13

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8466159

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1637

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9744170

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2035-01-02

Patent Use Code

U-1889

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9006387

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2030-06-10

Patent Use Code

U-1687

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING OMBITASVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8686026

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-06-09

Patent Use Code

Delist Requested

Application Number

206619

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8492386

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1840

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10201541

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2032-05-17

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10201584

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-05-17

Patent Use Code

U-1889

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9044480

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-04-10

Patent Use Code

U-1638

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9139536

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-11-09

Patent Use Code

U-1753

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING DISABUVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9006387

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2030-06-10

Patent Use Code

U-1687

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING OMBITASVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8686026

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-06-09

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8492386

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1840

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8268349

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-08-25

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8685984

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1840

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9044480

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-04-10

Patent Use Code

U-1638

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9139536

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-11-09

Patent Use Code

U-1753

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING DISABUVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8680106

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1637

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8466159

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1637

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8399015

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-08-25

Patent Use Code

Delist Requested

Application Number

206619

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8399015

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-08-25

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8420596

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2031-04-10

Patent Use Code

Delist Requested

Application Number

206619

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10201542

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-10-18

Patent Use Code

U-1753

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING DISABUVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8680106

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1637

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8642538

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-09-10

Patent Use Code

U-1638

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8685984

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2032-09-04

Patent Use Code

U-1840

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8268349

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-08-25

Patent Use Code

Delist Requested

Application Number

206619

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9629841

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-10-18

Patent Use Code

U-1753

Delist Requested

Application Number

206619

Patent Use Description

TREATMENT OF HCV INFECTION USING DISABUVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8188104

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-05-17

Patent Use Code

U-1636

Delist Requested

Application Number

206619

Patent Use Description

USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8420596

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2031-04-10

Patent Use Code

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8501238

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2028-09-17

Patent Use Code

U-1636

Delist Requested

Application Number

208624

Patent Use Description

USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10105365

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2035-01-02

Patent Use Code

U-1889

Delist Requested

Application Number

208624

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8642538

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-09-10

Patent Use Code

U-1638

Delist Requested

Application Number

208624

Patent Use Description

TREATMENT OF HCV INFECTION USING PARITAPREVIR

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8691938

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2032-04-13

Patent Use Code

Delist Requested

Application Number

206619

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8501238

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2028-12-19

Patent Use Code

U-1636

Delist Requested

Application Number

206619

Patent Use Description

USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR